<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD04220000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P01008</UniProt_ID>
  <Seq_Length>464</Seq_Length>
  <Molecule_Weight>52602</Molecule_Weight>
  <KEGG_ID>hsa:462</KEGG_ID>
  <Orthology_ID>K03911</Orthology_ID>
  <Function_Summary>Most important serine protease inhibitor in plasma that regulates the blood coagulation cascade. AT-III inhibits thrombin, matriptase-3/TMPRSS7, as well as factors IXa, Xa and XIa. Its inhibitory activity is greatly enhanced in the presence of heparin.</Function_Summary>
  <Pfam_ID>PF00079:Serpin</Pfam_ID>
  <Allosteric_Activator_Count>45</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>13</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>ATIII</Alias>
      <Alias>Serpin C1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme.</Detail>
      <Keyword>Serine-type endopeptidase inhibitor activity</Keyword>
      <Ontology_ID>GO:0004867</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Stops, prevents or reduces the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.</Detail>
      <Keyword>Peptidase inhibitor activity</Keyword>
      <Ontology_ID>GO:0030414</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha1-4-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.</Detail>
      <Keyword>Heparin binding</Keyword>
      <Ontology_ID>GO:0008201</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protease or peptidase.</Detail>
      <Keyword>Protease binding</Keyword>
      <Ontology_ID>GO:0002020</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>150</Position>
      <Original>Gln</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>414</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>161</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>398</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>127</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>381</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>391</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>73</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>219</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>441</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>302</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>160</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>167</Position>
      <Original>Asn</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>323</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>412</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>425</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>419</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>112</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>198</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>437</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>39</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>434</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>334</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>52</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>257</Position>
      <Original>Trp</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>152</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>438</Position>
      <Original>Arg</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>178</Position>
      <Original>Leu</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>397</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>425</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>251</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>416</Position>
      <Original>Ala</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>147</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>90</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>456</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>283</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>283</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>32</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>461</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>434</Position>
      <Original>Phe</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>79</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>223</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>95</Position>
      <Original>Tyr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>179</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>219</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>425</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>426</Position>
      <Original>Ser</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>261</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>243</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>95</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>214</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>56</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>190</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>121</Position>
      <Original>Met</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>439</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>453</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>214</Position>
      <Original>Ser</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>462</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>30</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>131</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>133</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>424</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>438</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>23</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>79</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>439</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>79</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>98</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>198</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>89</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>416</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>131</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>434</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>148</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>459</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>269</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>17</Position>
      <Original>Tyr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>457</Position>
      <Original>Arg</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>436</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>316</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.</Detail>
      <Keyword>Hemostasis</Keyword>
      <Ontology_ID>GO:0007599</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein.</Detail>
      <Keyword>Regulation of proteolysis</Keyword>
      <Ontology_ID>GO:0030162</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>68</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MYSNVIGTVTSGKRKVYLLSLLLIGFWDCVTCHGSPVDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK</Protein_Seq>
    <DNA_Seq>TCTGCCCCACCCTGTCCTCTGGAACCTCTGCGAGATTTAGAGGAAAGAACCAGTTTTCAGGCGGATTGCCTCAGATCACACTATCTCCACTTGCCCAGCCCTGTGGAAGATTAGCGGCCATGTATTCCAATGTGATAGGAACTGTAACCTCTGGAAAAAGGAAGGTTTATCTTTTGTCCTTGCTGCTCATTGGCTTCTGGGACTGCGTGACCTGTCACGGGAGCCCTGTGGACATCTGCACAGCCAAGCCGCGGGACATTCCCATGAATCCCATGTGCATTTACCGCTCCCCGGAGAAGAAGGCAACTGAGGATGAGGGCTCAGAACAGAAGATCCCGGAGGCCACCAACCGGCGTGTCTGGGAACTGTCCAAGGCCAATTCCCGCTTTGCTACCACTTTCTATCAGCACCTGGCAGATTCCAAGAATGACAATGATAACATTTTCCTGTCACCCCTGAGTATCTCCACGGCTTTTGCTATGACCAAGCTGGGTGCCTGTAATGACACCCTCCAGCAACTGATGGAGGTATTTAAGTTTGACACCATATCTGAGAAAACATCTGATCAGATCCACTTCTTCTTTGCCAAACTGAACTGCCGACTCTATCGAAAAGCCAACAAATCCTCCAAGTTAGTATCAGCCAATCGCCTTTTTGGAGACAAATCCCTTACCTTCAATGAGACCTACCAGGACATCAGTGAGTTGGTATATGGAGCCAAGCTCCAGCCCCTGGACTTCAAGGAAAATGCAGAGCAATCCAGAGCGGCCATCAACAAATGGGTGTCCAATAAGACCGAAGGCCGAATCACCGATGTCATTCCCTCGGAAGCCATCAATGAGCTCACTGTTCTGGTGCTGGTTAACACCATTTACTTCAAGGGCCTGTGGAAGTCAAAGTTCAGCCCTGAGAACACAAGGAAGGAACTGTTCTACAAGGCTGATGGAGAGTCGTGTTCAGCATCTATGATGTACCAGGAAGGCAAGTTCCGTTATCGGCGCGTGGCTGAAGGCACCCAGGTGCTTGAGTTGCCCTTCAAAGGTGATGACATCACCATGGTCCTCATCTTGCCCAAGCCTGAGAAGAGCCTGGCCAAGGTAGAGAAGGAACTCACCCCAGAGGTGCTGCAAGAGTGGCTGGATGAATTGGAGGAGATGATGCTGGTGGTCCACATGCCCCGCTTCCGCATTGAGGACGGCTTCAGTTTGAAGGAGCAGCTGCAAGACATGGGCCTTGTCGATCTGTTCAGCCCTGAAAAGTCCAAACTCCCAGGTATTGTTGCAGAAGGCCGAGATGACCTCTATGTCTCAGATGCATTCCATAAGGCATTTCTTGAGGTAAATGAAGAAGGCAGTGAAGCAGCTGCAAGTACCGCTGTTGTGATTGCTGGCCGTTCGCTAAACCCCAACAGGGTGACTTTCAAGGCCAACAGGCCTTTCCTGGTTTTTATAAGAGAAGTTCCTCTGAACACTATTATCTTCATGGGCAGAGTAGCCAACCCTTGTGTTAAGTAAAATGTTCTTATTCTTTGCACCTCTTCCTATTTTTGGTTTGTGAACAGAAGTAAAAATAAATACAAACTACTTCCATCTCACATTA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Plasma</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Secreted</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular space</CellLocal>
      <Ontology_ID>GO:0005615</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>SERPINC1</Gene_Name>
    <Gene_Alias>AT3</Gene_Alias>
    <Gene_ID>462</Gene_ID>
    <Genbank_ACCN>NM_000488</Genbank_ACCN>
    <Protein_ACCN>NP_000479</Protein_ACCN>
    <HGNC_ID>775</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/462</Gene_URL>
    <UCSC_ID>uc001gjt.3</UCSC_ID>
    <EMBL_ID>ENSG00000117601</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Venous Thromboembolism</Disease_Name>
      <Disease_Detail>Venous Thromboembolism</Disease_Detail>
      <Disease_DB>VNS010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/venous_thromboembolism?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Central Retinal Artery Occlusion</Disease_Name>
      <Disease_Detail>Central Retinal Artery Occlusion</Disease_Detail>
      <Disease_DB>CNT028</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/central_retinal_artery_occlusion?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Protein C Deficiency</Disease_Name>
      <Disease_Detail>Protein C Deficiency</Disease_Detail>
      <Disease_DB>PRT011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/protein_c_deficiency?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Septic Shock</Disease_Name>
      <Disease_Detail>Septic Shock</Disease_Detail>
      <Disease_DB>SPT013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/septic_shock?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Antithrombin Iii Deficiency</Disease_Name>
      <Disease_Detail>Antithrombin Iii Deficiency</Disease_Detail>
      <Disease_DB>ANT009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/antithrombin_iii_deficiency?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hypersplenism</Disease_Name>
      <Disease_Detail>Hypersplenism</Disease_Detail>
      <Disease_DB>HYP063</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hypersplenism?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sagittal Sinus Thrombosis</Disease_Name>
      <Disease_Detail>Sagittal Sinus Thrombosis</Disease_Detail>
      <Disease_DB>SGT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sagittal_sinus_thrombosis?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mitral Valve Stenosis</Disease_Name>
      <Disease_Detail>Mitral Valve Disease</Disease_Detail>
      <Disease_DB>MTR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mitral_valve_stenosis?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Homocysteine Plasma Level</Disease_Name>
      <Disease_Detail>Homocysteine Plasma Level</Disease_Detail>
      <Disease_DB>HMC004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/homocysteine_plasma_level?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Spinal Cord Infarction</Disease_Name>
      <Disease_Detail>Spinal Cord Infarction</Disease_Detail>
      <Disease_DB>SPN185</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spinal_cord_infarction?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Heparin-Induced Thrombocytopenia</Disease_Name>
      <Disease_Detail>Heparin-Induced Thrombocytopenia</Disease_Detail>
      <Disease_DB>HPR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/heparin_induced_thrombocytopenia?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Purpura</Disease_Name>
      <Disease_Detail>Purpura</Disease_Detail>
      <Disease_DB>PRP030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/purpura?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Central Retinal Vein Occlusion</Disease_Name>
      <Disease_Detail>Central Retinal Vein Occlusion</Disease_Detail>
      <Disease_DB>CNT016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/central_retinal_vein_occlusion?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Testicular Infarct</Disease_Name>
      <Disease_Detail>Testicular Infarct</Disease_Detail>
      <Disease_DB>TST007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/testicular_infarct?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thromboembolism</Disease_Name>
      <Disease_Detail>Thromboembolism</Disease_Detail>
      <Disease_DB>THR079</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thromboembolism?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pregnancy Loss</Disease_Name>
      <Disease_Detail>Pregnancy Loss</Disease_Detail>
      <Disease_DB>PRG060</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pregnancy_loss?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Retinal Vein Occlusion</Disease_Name>
      <Disease_Detail>Retinal Vein Occlusion</Disease_Detail>
      <Disease_DB>RTN022</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/retinal_vein_occlusion?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Weber Syndrome</Disease_Name>
      <Disease_Detail>Weber Syndrome</Disease_Detail>
      <Disease_DB>WBR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/weber_syndrome?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Fatty Liver of Pregnancy</Disease_Name>
      <Disease_Detail>Acute Fatty Liver of Pregnancy</Disease_Detail>
      <Disease_DB>ACT099</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_fatty_liver_of_pregnancy?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Eclampsia</Disease_Name>
      <Disease_Detail>Eclampsia</Disease_Detail>
      <Disease_DB>ECL001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/eclampsia?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myocardial Infarction</Disease_Name>
      <Disease_Detail>Myocardial Infarction</Disease_Detail>
      <Disease_DB>MYC007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myocardial_infarction?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pre-Eclampsia</Disease_Name>
      <Disease_Detail>Pre-Eclampsia</Disease_Detail>
      <Disease_DB>PRC016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pre_eclampsia?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Coronary Restenosis</Disease_Name>
      <Disease_Detail>Coronary Restenosis</Disease_Detail>
      <Disease_DB>CRN020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/coronary_restenosis?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Suppurative Otitis Media</Disease_Name>
      <Disease_Detail>Suppurative Otitis Media</Disease_Detail>
      <Disease_DB>SPP008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/suppurative_otitis_media?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acquired Angioedema</Disease_Name>
      <Disease_Detail>Acquired Angioedema</Disease_Detail>
      <Disease_DB>ACQ012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acquired_angioedema?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hellp Syndrome</Disease_Name>
      <Disease_Detail>Hellp Syndrome</Disease_Detail>
      <Disease_DB>HLL004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hellp_syndrome?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ischemic Colitis</Disease_Name>
      <Disease_Detail>Ischemic Colitis</Disease_Detail>
      <Disease_DB>ISC015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ischemic_colitis?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Severe Pre-Eclampsia</Disease_Name>
      <Disease_Detail>Severe Pre-Eclampsia</Disease_Detail>
      <Disease_DB>SVR005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/severe_pre_eclampsia?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Disseminated Intravascular Coagulation</Disease_Name>
      <Disease_Detail>Disseminated Intravascular Coagulation</Disease_Detail>
      <Disease_DB>DSS009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/disseminated_intravascular_coagulation?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Venous Thrombosis</Disease_Name>
      <Disease_Detail>Venous Thrombosis</Disease_Detail>
      <Disease_DB>VNS009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/venous_thrombosis?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dysfibrinogenemia</Disease_Name>
      <Disease_Detail>Dysfibrinogenemia</Disease_Detail>
      <Disease_DB>DYS026</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dysfibrinogenemia?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Portal Vein Thrombosis</Disease_Name>
      <Disease_Detail>Portal Vein Thrombosis</Disease_Detail>
      <Disease_DB>PRT018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/portal_vein_thrombosis?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Coronary Thrombosis</Disease_Name>
      <Disease_Detail>Coronary Thrombosis</Disease_Detail>
      <Disease_DB>CRN017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/coronary_thrombosis?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Congenital Antithrombin Deficiency</Disease_Name>
      <Disease_Detail>Congenital Antithrombin Deficiency</Disease_Detail>
      <Disease_DB>CNG056</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/congenital_antithrombin_deficiency?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor Vii Deficiency</Disease_Name>
      <Disease_Detail>Factor Vii Deficiency</Disease_Detail>
      <Disease_DB>FCT007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_vii_deficiency?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sepsis</Disease_Name>
      <Disease_Detail>Sepsis</Disease_Detail>
      <Disease_DB>SPS077</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sepsis?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Al Amyloidosis</Disease_Name>
      <Disease_Detail>Al Amyloidosis</Disease_Detail>
      <Disease_DB>ALM001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/al_amyloidosis?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Retinal Artery Occlusion</Disease_Name>
      <Disease_Detail>Retinal Artery Occlusion</Disease_Detail>
      <Disease_DB>RTN014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/retinal_artery_occlusion?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Legg-Calve-Perthes Disease</Disease_Name>
      <Disease_Detail>Legg-Calve-Perthes Disease</Disease_Detail>
      <Disease_DB>LGG001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/legg_calve_perthes_disease?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Congenital Antithrombin Deficiency Type 3</Disease_Name>
      <Disease_Detail>Congenital Antithrombin Deficiency</Disease_Detail>
      <Disease_DB>CNG058</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/congenital_antithrombin_deficiency_type_3?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Renovascular Hypertension</Disease_Name>
      <Disease_Detail>Renovascular Hypertension</Disease_Detail>
      <Disease_DB>RNV001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/renovascular_hypertension?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Otitis Media</Disease_Name>
      <Disease_Detail>Otitis Media</Disease_Detail>
      <Disease_DB>OTT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/otitis_media?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Peripheral Vertigo</Disease_Name>
      <Disease_Detail>Peripheral Vertigo</Disease_Detail>
      <Disease_DB>PRP028</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/peripheral_vertigo?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sneddon Syndrome</Disease_Name>
      <Disease_Detail>Sneddon Syndrome</Disease_Detail>
      <Disease_DB>SND002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sneddon_syndrome?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thrombophlebitis</Disease_Name>
      <Disease_Detail>Thrombophlebitis</Disease_Detail>
      <Disease_DB>THR016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thrombophlebitis?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Blood Protein Disease</Disease_Name>
      <Disease_Detail>Blood Protein Disease</Disease_Detail>
      <Disease_DB>BLD054</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/blood_protein_disease?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Factor Xii Deficiency</Disease_Name>
      <Disease_Detail>Factor Xii Deficiency</Disease_Detail>
      <Disease_DB>FCT004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/factor_xii_deficiency?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Binswanger's Disease</Disease_Name>
      <Disease_Detail>Binswanger's Disease</Disease_Detail>
      <Disease_DB>BNS003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/binswangers_disease?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Myocardial Stunning</Disease_Name>
      <Disease_Detail>Myocardial Stunning</Disease_Detail>
      <Disease_DB>MYC005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/myocardial_stunning?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hereditary Antithrombin Deficiency</Disease_Name>
      <Disease_Detail>Hereditary Antithrombin Deficiency</Disease_Detail>
      <Disease_DB>HRD083</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hereditary_antithrombin_deficiency?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Klippel-Trenaunay Syndrome</Disease_Name>
      <Disease_Detail>Klippel-Trenaunay Syndrome</Disease_Detail>
      <Disease_DB>KLP002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/klippel_trenaunay_syndrome?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Congenital Disorder of Glycosylation Type 1a</Disease_Name>
      <Disease_Detail>Congenital Disorder of Glycosylation</Disease_Detail>
      <Disease_DB>CNG224</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/congenital_disorder_of_glycosylation_type_1a?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Branch Retinal Artery Occlusion</Disease_Name>
      <Disease_Detail>Branch Retinal Artery Occlusion</Disease_Detail>
      <Disease_DB>BRN026</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/branch_retinal_artery_occlusion?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intermediate Coronary Syndrome</Disease_Name>
      <Disease_Detail>Intermediate Coronary Syndrome</Disease_Detail>
      <Disease_DB>INT007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intermediate_coronary_syndrome?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Protein S Deficiency</Disease_Name>
      <Disease_Detail>Protein S Deficiency</Disease_Detail>
      <Disease_DB>PRT014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/protein_s_deficiency?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Meningococcemia</Disease_Name>
      <Disease_Detail>Meningococcemia</Disease_Detail>
      <Disease_DB>MNN021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/meningococcemia?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dysplasminogenemia</Disease_Name>
      <Disease_Detail>Dysplasminogenemia</Disease_Detail>
      <Disease_DB>DYS157</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dysplasminogenemia?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Carotid Artery Thrombosis</Disease_Name>
      <Disease_Detail>Carotid Artery Thrombosis</Disease_Detail>
      <Disease_DB>CRT004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/carotid_artery_thrombosis?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cerebral Sinovenous Thrombosis</Disease_Name>
      <Disease_Detail>Cerebral Sinovenous Thrombosis</Disease_Detail>
      <Disease_DB>CRB132</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cerebral_sinovenous_thrombosis?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hemorrhagic Fever</Disease_Name>
      <Disease_Detail>Hemorrhagic Fever</Disease_Detail>
      <Disease_DB>HMR012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hemorrhagic_fever?search=SERPINC1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of the antithrombin-factor IXa-pentasaccharide complex</PDB_Title>
      <PDB_ID>3KCG</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KCG</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04220038</ASD_Ligand>
      <PubMed_Title>Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.</PubMed_Title>
      <Author>Johnson, D.J., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2010)107:645-650</Journal>
      <PubMed_ID>20080729</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE</PDB_Title>
      <PDB_ID>1E03</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1E03</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04220038</ASD_Ligand>
      <PubMed_Title>Structure of Beta-Antithrombin and the Effect of Glycosylation on Antithrombin'S Heparin Affinity and Activity.</PubMed_Title>
      <Author>Mccoy, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(2003)326:823</Journal>
      <PubMed_ID>12581643</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Native Antithrombin in its Monomeric Form</PDB_Title>
      <PDB_ID>1T1F</PDB_ID>
      <Resolution>2.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1T1F</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation</PubMed_Title>
      <Author>Johnson, D.J.D., et al.</Author>
      <Journal>J.Biol.Chem.(2006)281:35478-35486</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16973611?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Antithrombin in the Pentasaccharide-Bound Intermediate State</PDB_Title>
      <PDB_ID>1NQ9</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NQ9</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04220038</ASD_Ligand>
      <PubMed_Title>Crystal Structure of Antithrombin in a Heparin-Bound Intermediate State</PubMed_Title>
      <Author>Johnson, D.J.D., et al.</Author>
      <Journal>Biochemistry(2003)42:8712-8719</Journal>
      <PubMed_ID>12873131</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Antithrombin-III</PDB_Title>
      <PDB_ID>2B4X</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2B4X</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of Antithrombin-III</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure at 2.6A of the ternary complex between antithrombin, a P14-P8 reactive loop peptide, and an exogenous tetrapeptide</PDB_Title>
      <PDB_ID>1JVQ</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1JVQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>How small peptides block and reverse serpin polymerisation</PubMed_Title>
      <Author>Zhou, A., et al.</Author>
      <Journal>J.Mol.Biol.(2004)342:931-941</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15342247?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>N135Q-S380C-ANTITHROMBIN-III</PDB_Title>
      <PDB_ID>1DZG</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DZG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Conformational Activation of Antithrombin. A 2. 85-A Structure of a Fluorescein Derivative Reveals an Electrostatic Link between the Hinge and Heparin Binding Regions.</PubMed_Title>
      <Author>Huntington, J.A., et al.</Author>
      <Journal>J.Biol.Chem.(2000)275:15377</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10809774?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE</PDB_Title>
      <PDB_ID>2ANT</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ANT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site.</PubMed_Title>
      <Author>Skinner, R., et al.</Author>
      <Journal>J.Mol.Biol.(1997)266:601-609</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9067613?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of antithrombin variant S137A/V317C/T401C with plasma latent antithrombin</PDB_Title>
      <PDB_ID>2BEH</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2BEH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation.</PubMed_Title>
      <Author>Johnson, D.J., et al.</Author>
      <Journal>J.Biol.Chem.(2006)281:35478-35486</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16973611?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of dimeric antithrombin complexed with a P14-P9 reactive loop peptide and an exogenous tripeptide</PDB_Title>
      <PDB_ID>1LK6</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LK6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Serpin Polymerization Is Prevented by a Hydrogen Bond Network That Is Centered on His-334 and Stabilized by Glycerol</PubMed_Title>
      <Author>Zhou, A., et al.</Author>
      <Journal>J.Biol.Chem.(2003)278:15116-15122</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12578831?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III</PDB_Title>
      <PDB_ID>1DZH</PDB_ID>
      <Resolution>2.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1DZH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Conformational Activation of Antithrombin. A 2. 85-A Structure of a Fluorescein Derivative Reveals an Electrostatic Link between the Hinge and Heparin Binding Regions.</PubMed_Title>
      <Author>Huntington, J.A., et al.</Author>
      <Journal>J.Biol.Chem.(2000)275:15377</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10809774?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN</PDB_Title>
      <PDB_ID>1BR8</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1BR8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin.</PubMed_Title>
      <Author>Skinner, R., et al.</Author>
      <Journal>J.Mol.Biol.(1998)283:9-14</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9761669?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>2.1 Angstrom structure of a nonproductive complex between antithrombin, synthetic heparin mimetic SR123781 and two S195A thrombin molecules</PDB_Title>
      <PDB_ID>2B5T</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2B5T</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation.</PubMed_Title>
      <Author>Johnson, D.J., et al.</Author>
      <Journal>J.Biol.Chem.(2006)281:35478-35486</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16973611?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Intermediate structure of antithrombin bound to the natural pentasaccharide</PDB_Title>
      <PDB_ID>3EVJ</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3EVJ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04220039</ASD_Ligand>
      <PubMed_Title>Intermediate structure of antithrombin bound to the natural pentasaccharide</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of P13 Alanine Variant of Antithrombin</PDB_Title>
      <PDB_ID>1OYH</PDB_ID>
      <Resolution>2.62</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1OYH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The influence of hinge region residue Glu-381 on antithrombin allostery and metastability</PubMed_Title>
      <Author>Johnson, D.J.D., et al.</Author>
      <Journal>J.Biol.Chem.(2004)279:4913-4921</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14623882?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>PLASMA BETA ANTITHROMBIN-III</PDB_Title>
      <PDB_ID>1E04</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1E04</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of Beta-Antithrombin and the Effect of Glycosylation on Antithrombin'S Heparin Affinity and Activity.</PubMed_Title>
      <Author>Mccoy, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(2003)326:823</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12581643?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of P14 Alanine Variant of Antithrombin</PDB_Title>
      <PDB_ID>2HIJ</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2HIJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of P14 Alanine Variant of Antithrombin</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS</PDB_Title>
      <PDB_ID>1ATH</PDB_ID>
      <Resolution>3.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ATH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions.</PubMed_Title>
      <Author>Schreuder, H.A., et al.</Author>
      <Journal>Nat.Struct.Biol.(1994)1:48-54</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7656006?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>PLASMA ALPHA ANTITHROMBIN-III</PDB_Title>
      <PDB_ID>1E05</PDB_ID>
      <Resolution>2.62</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1E05</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of Beta-Antithrombin and the Effect of Glycosylation on Antithrombin'S Heparin Affinity and Activity.</PubMed_Title>
      <Author>Mccoy, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(2003)326:823</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12581643?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN</PDB_Title>
      <PDB_ID>1ANT</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ANT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Biological implications of a 3 A structure of dimeric antithrombin.</PubMed_Title>
      <Author>Carrell, R.W., et al.</Author>
      <Journal>Structure(1994)2:257-270</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8087553?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>2.5A Crystal Structure of the Antithrombin-Thrombin-Heparin Ternary Complex</PDB_Title>
      <PDB_ID>1TB6</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1TB6</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04220055;ASD04220056;ASD04220057;ASD04220058;ASD04220059;ASD04220060</ASD_Ligand>
      <PubMed_Title>Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin.</PubMed_Title>
      <Author>Li, W., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2004)11:857-862</Journal>
      <PubMed_ID>15311269</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of a Domain-Swapped Serpin Dimer</PDB_Title>
      <PDB_ID>2ZNH</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ZNH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization</PubMed_Title>
      <Author>Yamasaki, M., et al.</Author>
      <Journal>Nature(2008)455:1255-1258</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18923394?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of dimeric antithrombin complexed with a P14-P9 reactive loop peptide and an exogenous tripeptide (formyl-norleucine-LF)</PDB_Title>
      <PDB_ID>1R1L</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1R1L</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Serpins and the design of peptides to block intermolecular beta-linkages</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>ANTITHROMBIN/PENTASACCHARIDE COMPLEX</PDB_Title>
      <PDB_ID>1AZX</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1AZX</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04220038</ASD_Ligand>
      <PubMed_Title>The anticoagulant activation of antithrombin by heparin.</PubMed_Title>
      <Author>Jin, L., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(1997)94:14683-14688</Journal>
      <PubMed_ID>9405673</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the Antithrombin-S195A Factor Xa-Pentasaccharide Complex</PDB_Title>
      <PDB_ID>2GD4</PDB_ID>
      <Resolution>3.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GD4</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04220039</ASD_Ligand>
      <PubMed_Title>Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.</PubMed_Title>
      <Author>Johnson, D.J., et al.</Author>
      <Journal>Embo J.(2006)25:2029-2037</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16619025?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE</PDB_Title>
      <PDB_ID>1SR5</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1SR5</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD04220054</ASD_Ligand>
      <PubMed_Title>The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.</PubMed_Title>
      <Author>Dementiev, A., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2004)11:863-867</Journal>
      <PubMed_ID>15311268</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04610</Pathway_ID>
      <Pathway_Title>Complement and coagulation cascades</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Multi-domain proteins (alpha and beta)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.f.b.b.b.g.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1ant</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,77,Asn;site,78,Arg;site,79,Arg;site,146,Lys;site,157,Lys;site,161,Arg</Site_Detail>
      <Site_Reference>Johnson DJ, et al. EMBO J. 2006,25(9):2029-2037.</Site_Reference>
      <Site_Type>Two sequential conformational changes</Site_Type>
      <PDB_ID>1AZX;1E03;1NQ9;1SR5;2GD4;3EVJ;3KCG</PDB_ID>
      <PubMed_ID>16619025</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD02250006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220003</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220004</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220005</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220006</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220007</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220008</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220009</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220010</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220013</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220014</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220015</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220016</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220017</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220018</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220019</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220020</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220021</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220022</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220023</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220024</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220025</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220026</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220027</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220028</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220029</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220030</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220031</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220032</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220033</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220034</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220035</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220036</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220037</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220038</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220039</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220040</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220042</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220043</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220044</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220045</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220046</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220047</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220048</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220049</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220050</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220051</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220054</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220055</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220056</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220057</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220058</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220059</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD04220060</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>